Stocks
GlaxoSmithKline (GSK) Cash US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Cash, £ | 7 877 000 000 | 7 877 000 000 | 7 877 000 000 | 5 182 000 000 | 5 688 000 000 | 3 212 000 000 | |||
| Changes by years, y/y, % | +82% | 0% | 0% | -34% | +10% | +7.5% | |||
GlaxoSmithKline. Cash, £
GlaxoSmithKline. Cash, changes, %
GlaxoSmithKline (GSK) Cash US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| Cash, £ | 2 983 000 000 | 4 095 000 000 | 3 212 000 000 | 2 983 000 000 | 3 212 000 000 | 3 212 000 000 | ||
| Changes by years, y/y, % | -54% | -41% | -52% | -54% | -52% | |||
| Changes by quarters, q/q, % | -42% | +37% | -22% | -7% | +8% | |||
